PI
AGIO icon

PEAK6 Investments’s Agios Pharmaceuticals AGIO Stock Holding History

PEAK6 Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-57,400
Closed -$2.04M – 4318
2020
Q1 		$2.04M Buy
+57,400
New +$2.65M 0.01% 1016
2018
Q4 		– Sell
-27,200
Closed -$2.1M – 3920
2018
Q3 		$2.1M Buy
+27,200
New +$2.19M 0.01% 1397

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Investments's AGIO Position: Q2 2020 in Review

PEAK6 Investments sold out of Agios Pharmaceuticals (AGIO) in Q2 2020, closing a stake of 34,631 shares — an estimated $1.23M sold.

PEAK6 Investments first reported a position in AGIO in Q3 2018 and held it in 2 quarters. The position peaked at $1.23M in Q1 2020. 216 funds tracked by Wall St. Rank hold AGIO as of Q2 2020.

  • PEAK6 Investments reported no remaining Agios Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • PEAK6 Investments sold 34,631 Agios Pharmaceuticals shares in Q2 2020, an estimated $1.23M.
  • PEAK6 Investments first reported a position in Agios Pharmaceuticals in Q3 2018 and held it in 2 quarters.
  • PEAK6 Investments's Agios Pharmaceuticals position peaked at $1.23M in Q1 2020.
  • 216 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2020.

Based on PEAK6 Investments's 13F filing for Q2 2020, filed 14 Aug 2020.